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Procedural Results and Acute Complications in Stenting
Native and Recurrent Coarctation of the Aorta in
Patients Over 4 Years of Age: A Multi-Institutional Study
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Makram R. Ebeid,7 MD, Ziyad M. Hijazi,8 MD, Satinder Sandhu,8 MD, Donald J. Hagler,9 MD,
Horst Sievert,10 MD, Thomas E. Fagan,11 MD, Jeremy Ringewald,12 MD, Wei Du,1 PhD,
Liwen Tang,1 MD, MS, David F. Wax,13 MD, John Rhodes,14 MD, Troy A. Johnston,15 MD,
Thomas K. Jones,15 MD, Daniel R. Turner,1 MD, Carlos A.C. Pedra,16 MD, and
William E. Hellenbrand,17 MD, Congenital Cardiovascular Interventional
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Background: We report a multi-institutional experience with intravascular stenting (IS)
for treatment of coarctation of the aorta. Methods and Results: Data was collected
retrospectively by review of medical records from 17 institutions. The data was broken
down to prior to 2002 and after 2002 for further analysis. A total of 565 procedures
were performed with a median age of 15 years (mean ¼ 18.1 years). Successful reduc-
tion in the post stent gradient (<20 mm Hg) or increase in post stent coarctation to de-
scending aorta (DAo) ratio of >0.8 was achieved in 97.9% of procedures. There was
significant improvement (P < 0.01) in pre versus post stent coarctation dimensions (7.4
mm 6 3.0 mm vs. 14.3 6 3.2mm), systolic gradient (31.6 mm Hg 6 16.0 mm Hg vs. 2.7
mm Hg 6 4.2 mm Hg) and ratio of the coarctation segment to the DAo (0.43 6 0.17 vs.
0.85 6 0.15). Acute complications were encountered in 81/565 (14.3%) procedures.
There were two procedure related deaths. Aortic wall complications included: aneu-
rysm formation (n ¼ 6), intimal tears (n ¼ 8), and dissections (n ¼ 9). The risk of aortic
dissection increased significantly in patients over the age of 40 years. Technical com-
plications included stent migration (n ¼ 28), and balloon rupture (n ¼ 13). Peripheral
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vascular complications included cerebral vascular accidents (CVA) (n ¼ 4), peripheral
emboli (n ¼ 1), and significant access arterial injury (n ¼ 13). Older age was signifi-
cantly associated with occurrence of CVAs. A significant decrease in the technical
complication rate from 16.3% to 6.1% (P < 0.001) was observed in procedures per-
formed after January 2002. Conclusions: Stent placement for coarctation of aorta is
an effective treatment option, though it remains a technically challenging procedure.
Technical and aortic complications have decreased over the past 3 years due to, in
part, improvement in balloon and stent design. Improvement in our ability to assess
aortic wall compliance is essential prior to placement of ISs in older patients with co-
arctation of the aorta. ' 2007 Wiley-Liss, Inc.
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INTRODUCTION
Coarctation of the aorta affects 5–8% of patients with
congenital heart disease. The initial treatment option
was surgical resection with end-to-end anastomosis, first
described by Crafoord in 1945 [1]. Over the past 15
years, balloon expandable intravascular stent (IS) place-
ment for treatment of both native and recurrent coarcta-
tion of the aorta has gained acceptance in older children
and adults [2–14]. Placement of ISs can be technically
challenging and has been associated with serious com-
plications. We report a multi-institutional experience in
placement of ISs for the treatment of native and recur-
rent coarctation of the aorta. The primary focus of this
study was to evaluate the efficacy of the procedure,
determine risk factors for encountering acute complica-
tions, and relate consequences of the complications.
METHODS
Patients
All consecutive patients who underwent stenting at
the 17 participating institutions were included. Deci-
sion to undergo IS versus balloon angioplasty or sur-
gery was dependent upon the interventionalist, with no
criteria being set as to who received which procedure.
Patients under 4 years of age were excluded from
the study. The patient’s (or guardian’s) consent and
the institution’s Institutional Review Board approval
were obtained. This was a retrospective study, and the
data collection method was by way of extensive chart
review. Data sheets were sent to each participating
center, with the staff physician or research assistant
performing data entry. To ensure patient confidential-
ity, no patient identifying information was shared
between participating institutions.
Definitions
Coarctation of the aorta was defined as ‘‘the pres-
ence of systemic hypertension with an upper to lower
limb systolic blood pressure difference 20 mm Hg or
an upper to lower extremity blood pressure differential
<20 mm Hg in the presence of systemic hypertension
or left ventricular hypertrophy, and confirmation of the
coarctation by computerized tomography (CT) scan,
magnetic resonance imaging, or echocardiographic
assessment.’’ In some patients, the obstruction
occurred at the level of the transverse aortic arch. In
these cases, the ratio of diameter of the narrowed seg-
ment to the diameter of the descending aorta (DAo) at
the level of the diaphragm of less than 0.6 was used to
define coarctation [15,16] in the presence of clinical
evidence of coarctation. Discrete coarctation was
defined as a coarctation segment measuring 5 mm,
with long segment coarctation measuring >5 mm. Suc-
cessful outcome was defined as a ‘‘peak residual sys-
tolic catheterization gradient of less than 20 mm Hg
following stent implantation and the absence of serious
complications (death, requirement of surgery, perma-
nent disability). Post stent peak gradients of 10 mm
Hg were also calculated for comparisons with our defi-
nition, with further assessment regarding transverse
arch anatomy being obtained to discern what role
transverse arch hypoplasia played in residual coarcta-
tion gradient. Acute complications were defined as
complications requiring additional procedures during
the intervention, or additional observation/therapy prior
to discharge from the hospital. They were categorized
into aortic wall complications, technical complications,
or peripheral vascular complications. Aortic wall com-
plications included intimal tears, dissection (including
aortic wall rupture), or the development of an aneu-
rysm. Aneurysm was defined as an expansion of the
aortic wall >10% from the adjoining native lumen that
was absent prior to the intervention. Dissection was
defined as extravasation of contrast outside the vessel
lumen, and intimal tear was defined as a filling defect
observed within the vessel lumen with no evidence of
extravasation outside the vessel lumen (either proximal
or distal to previously placed stent. Aortic rupture was
listed as dissection in our analysis. Technical compli-
cations included balloon rupture or migration of the
stent off the balloon during deployment or immediately
following deployment. Peripheral vascular complica-
tions included cerebral vascular accident (CVA), pe-
ripheral emboli, or significant vascular entry injury
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requiring observation, surgical repair or anticoagulant
therapy. Peripheral vascular complications were
grouped under technical complications in our analysis.
Overlapping the origin of a brachiocephalic vessel by
the stent was not considered a complication, though will
be discussed as a separate observation.
Study Data
Data collected included patient demographics; charac-
terization of coarctation (discrete vs. long segment), co-
arctation location, other associated diagnosis, angio-
graphic dimensions pre and post stenting, diameter of the
coarctation; pre and post intervention systolic gradient,
pre and post intervention coarctation:DAo and balloon:
coarctation ratios. Technical data collected included: the
use of general anesthesia, guide wire position, type and
size of balloon used, sheath size, and type of stent used.
The presence of complications was noted, as well as
maneuvers performed to correct the complication.
Statistical Analysis
Descriptive statistics such as mean, median, SD, and
frequency were calculated for each demographic and
clinical characteristic whenever appropriate. Compari-
sons for continuous pre and post intervention data end
points were performed using the paired t tests. Chi-
square tests, two-sample t tests, and Pearson correla-
tion were used to assess the degree of association
between various patient characteristics. Logistic regres-
sion analyses were performed to assess the role of
patient age, time of procedure, coarctation anatomy,
balloon size, etc, in relation with the development of
complications. The odds-ratio (OR) of any significant
patient factors (P-value < 0.05) from the logistic
regression analyses are reported along with their P-val-




Seventeen institutions (Table I) participated in this
study (14 within the United States, 2 in Europe, and 1 in
Brazil). The earliest procedure was performed in May
1989 and the most recent in August 2005. Five hundred
and sixty-five instravascular stent procedures were per-
formed, with a total of 627 stents being placed in 555
patients for treatment of native or recurrent coarctation
of the aorta. The results of 139 procedures have been
previously reported [2,10,12–14]. Pertinent patient
demographics, including age and procedures performed
prior to 2002 and after 2002, are tabulated in Table II.
Characteristics of the coarctation. Native coarcta-
tion was present in 52.3% and located at the isthmus
in 81.4% of the procedures. Further details are pro-
vided in Table III.
Technical characteristics. As shown in Table IV,
prestent angioplasty was performed in 17.6% of proce-
dures where records were available. The mean balloon
dimension was 15.2 mm 6 3.6 mm. The median bal-
loon: coarctation ratio was 2 (range 1.1–18). Over
89% of stents were delivered either on Z-Med (Braun,
Bethlehem, Penn), Balloon in balloon (BIB) (NuMED,
Hopkinton, NY), or Cordis (Warren, NJ) balloons. Pal-
maz ‘‘8’’ and ‘‘10’’ series and the Genesis XD stent
(Cordis) series were used in over 83.8% of the stent
procedures, with the Genesis XD and Palmaz ‘‘10’’ se-
ries being the most widely used stents since 2001. The
DS/Mega/Maxi stents (EV3, Bloomington, MN) and









1 50 4 (8)a 36
2 9 4 (44.4) 4
3 98 8 (8.2) 42
4 57 11 (19.3) 28
5 23 2 (8.7) 14
6 23 2 (8.7) 11
7 42 13 (31) 2
8 11 1 (9.1) 8
9 8 2 (25) 8
10 33 6 (18.2) 9
11 48 5 (10.4) 14
12 14 5 (35.7) 5
13 7 1 (14.3) 5
14 10 0 (0) 5
15 55 8 (14.6) 25
16 8 0 (0) 0
17 69 8 (11.6) 48
aValues in parentheses indicate percentages.
TABLE II. Patient Characteristics
Age distribution
4–9 yrs old (n) 74 (13.1)a
10–19 yrs old (n) 24 (57.4)
20–29 yrs old (n) 88 (15.6)
30–39 yrs old (n) 37 (6.6)
40 + yrs (n) 42 (7.4)
Median of age 15 yrs [4–4.9 yrs]b
Median of patient weight 56.4 kg [3.8–145 kg]
Patient diagnoses
Isolated coarctation (n) 242 (42.8)
Bicuspid aortic valve or Shone’s complex (n) 148 (26.2)
Vasculitis (n) 8 (1.4)
Other (n) 121 (21.4)
Missing (n) 46 (8.1)
Procedures prior to January 1, 2002 (n) 301 (53.3)
Procedures after January 1, 2002 (n) 264 (46.7)
aValues in parentheses indicate percentages.
bValues in square brackets indicate ranges.
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Cheatham-Platinum, covered and uncovered (NuMED,
Hopkinton, NY) made up the remainder of the stents
used.
Success of Procedure
A successful treatment outcome was achieved in
553/565 (97.9%) procedures. In the successful group,
the peak systolic ascending to descending aortic gradi-
ent decreased from a mean 31.6 6 16.0 mm Hg to 2.7
6 4.2 mm Hg (P < 0.001). The mean diameter of the
coarctation segment significantly increased from 7.4 6
3.0 mm to 14.3 6 3.2 mm (P < 0.001), and the mean
coarctation: descending aortic ratio significantly in-
creased from 0.43 6 0.17 to 0.85 6 0.15 (P < 0.001).
Twelve procedures were unsuccessful as defined pre-
viously. Though the low number of unsuccessful pro-
cedures precluded any meaningful analysis, certain
observations were noted. In two patients who under-
went stent placement of their ascending to descending
aortic conduit, both were unsuccessful, with one hav-
ing acute rupture of his aorta and subsequently expir-
ing. Six each had native and recurrent coarctation of
the aorta. Five of the 12 had a gradient of more than
60 mm Hg across the coarctation prior to stenting.
Two patients (one previously mentioned earlier) had
dissection with subsequent aortic rupture post stent
placement leading to termination of the procedure and
emergent surgery. Success, when defined as a post
stent coarctation systolic gradient 10 mm Hg, was
noted in 92.2% (521/565) patients, with failures being
observed in 7.8% (44/565) patients. The increase in
unsuccessful procedures was felt to be due to planned
staged procedure (n ¼ 10) and transverse arch hypo-
plasia. (n ¼ 22), as in each of these cases the post
stent coarctation:descending aortic ratio was 0.80. In
using <10 mm Hg post stent gradient as our criteria
for success, we performed further sub analysis of the
data. Success was increased in treatment of discrete
versus long segment coarctation (94.6 vs 84.5%; P <
0.001), increased preprocedure coarctation diameter
(7.4 vs 5.4 mm; SD 2.7, P ¼ 0.03), and lower prestent
systolic gradient 29.5 versus 38.1 mmHg; SD 16.9, P
< 0.001). Patients’ age, weight, location of coarctation,
native versus recurrent coartation, and balloon:coarcta-
tion ratio were not associated with successful outcome.
Complications
Complications were encountered in 81/565 (14.3%)
procedures. The complication rate significantly de-
creased in procedures performed after January 2002
(Fig. 1). Complications were further broken down into
Aortic wall and Technical complications for the fol-
lowing analyses. Encountering complications, either in
total or divided into aortic wall and technical was not
related to center volume.
Aortic wall complications. Acute aortic wall com-
plications were encountered in 22/565 (3.9%) proce-
dures. Intimal tears were noted in eight procedures,
aortic wall dissection/rupture was encountered in nine
procedures, and aortic aneurysm was noted in six
procedures. Performing prestent balloon angioplasty,
(11.4% vs. 3%; OR ¼ 4.18; P ¼ 0.001), location of
the coarctation in the abdominal aorta versus the isthmus/
transverse aortic arch (17.4% vs. 3.5%; OR ¼ 5.74;
TABLE IV. Technical Characteristics
Characteristics
General anesthesia used in: n ¼ 366 pts 259 (70.8)a
Median of sheath size in Fr 11 [6–16]b
Balloon type: n ¼ 423 ptsc
Z-med 118 (27.9)
Cordis 71 (16.8)
Balloon in balloon 188 (44.4)
XXL 19 (4.5)
Other 27 (6.4)
Prestent angioplasty: n ¼ 449 pts 79 (17.6)
Balloon dimension: n ¼ 565 pts Mean 6 S.D. 15.2 6 3.6 mm
Median balloon:Coarctation ratio 2 [1.1–18]
Initial stent type: n ¼ 511 pts












aValues in parentheses indicate percentages.
bValues in square brackets indicate ranges.
cMissing data accounts for the missing percentage.




Recurrent surgical 228 (40.4)
Recurrent interventional
Post balloon angioplasty 21 (3.7)
Post stent 20 (3.5)
Location of coarctation
Isthmus 341 (81.4)




Long segment 110 (25.3)
aMissing data accounts for the missing percentage in each characteristic.
bValues in parentheses indicate percentages.
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P < 0.01), and age over 40 (9.5% vs. 3.4%; OR ¼
2.95; P ¼ 0.05) were all significantly related to
encountering an aortic wall complication (Table V).
IS treatment of long segment coarctation (7.3% vs.
3.1%; OR ¼ 2.47; P ¼ 0.06) trended towards encoun-
tering acute aortic wall complications.
Intimal tear. Intimal tears were encountered in 8/
565 (1.4%) of the procedures. In 5/8 procedures, the
intimal tear occurred just proximal to the stent. In one
patient with recurrent post surgical coarctation, an inti-
mal tear was preceded by balloon rupture and stent
migration. A second stent was successfully implanted
at the coarctation site during the same procedure. All
other intimal tears occurring during IS placement were
not preceded by a technical complication, with none
requiring any immediate reintervention.
Aortic dissection. Nine out of 565 procedures
(4.6%) encountered dissection of the aorta/interposition
graft during initial stent placement. In one patient the
development of a dissection was preceded by stent
migration. In the other eight patients, no technical com-
plications were encountered during stent deployment.
Three patients (two aortic stents, one interposition graft
stent patient) were sent emergently to surgery, includ-
ing the one preceded by stent migration. Two of the
three patients suffered severe neurological injuries,
with one expiring the following day (interposition graft
stent) and the other 6 months later (aortic stent). Three
patients underwent successful placement of one, two,
and three covered stents, respectively. The three
remaining patients were managed medically with close
ICU monitoring and aggressive regimen of antihyper-
tensive medications. Resolution of the aortic dissection
was observed at follow-up one month later in one
patient (Fig. 2a–d).
Technical complications. Technical complications
were encountered in 59/565 (10.4%) procedures. Five
procedures had more than one complication, making a
total of 64 technical complications. Technical compli-
cations included: stent migration (n ¼ 28), balloon
rupture (n ¼ 13), and encountering a CVA or periph-
eral embolic event (n ¼ 5). Vascular site hematoma (n
¼ 13) is discussed separately though was also counted
as a technical complication. The majority of technical
complications (90%) encountered were resolved with-
out any clinical sequellae, with seven (10%) proce-
dures being associated with aortic wall injury, CVA,
or peripheral vascular complications. The risk of
encountering a technical complication increased in
patients over the age of 40 years, (23.8% vs. 10.5%;
OR ¼ 2.65; P ¼ 0.01), decreased with the use of anes-
thesia (5.8% vs. 19.8%; OR ¼ 0.25; P < 0.001), and
decreased with a procedure date after January 1, 2002
(6.1% vs. 16.3%; OR ¼ 0.33; P < 0.001) (Fig. 1).
The risk of encountering a technical complication, ei-
ther prior to January 2002 or after January 2002, was
not associated with, weight, type, or location of coarc-
tation, initial coarctation diameter, balloon:coarctation
ratio, mean balloon diameter, the presence of other
associated diagnosis, prestent angioplasty, use of the
BIB balloon, stent type, or institution at which proce-
dure was performed. Cardiac rate controlling measures
were not used in any of the patient’s undergoing stent
placement. Furthermore, in institutions where >40 IS
TABLE V. Complications Split up by Age Group
Age group (yrs) 4–9 10–19 20–29 30–39 >40 Total
Number of patients 74 324 88 37 42 565
All complications 6 (8.1) 44 (13.6) 11 (12.5) 6 (16.2) 13 (31) 81 (14.3)
Aortic wall complication 1 (1) 11 (3.4) 4 (4.6) 2 (5.4) 4 (9.5) 22 (3.7)
Technical complication 9 (10.7) 36 (11.1) 9 (10.3) 6 (16.2) 10 (23.8) 71 (12.1)
Fig. 1. Comparisons of complications, further broken down
into aortic wall and technical complications prior to and fol-
lowing January 1, 2002.
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placement procedures have been performed, no differ-
ence in encountering technical complications were
noted in comparing early (initial 25 stent procedures)
versus late experience at each respective institution.
Stent migration. Stent migration was the most fre-
quently encountered technical complication, occurring
in 28/565 (5%) procedures. The major cause for stent
migration was delivery of the stent on a balloon cathe-
ter that was larger than the aorta proximal to the co-
arctation site (>2 mm). This was observed in 14 out
of the 28 procedures. The second most common cause
of stent migration (n ¼ 9) related to deployment of the
stent on an undersized balloon where the coarctation
site was not a true stenosis, but more of a fold in the
aortic arch (pseudocoarctation). Balloon rupture was
implicated in five stent migrations. Stent migration
trended towards occurring on larger balloon sizes, with
18/28 (64%) stents migrating when the delivery bal-
loon diameter was greater than or equal to 15 mm.
Thirteen of 28 migrated stents were successfully repo-
sitioned and did not require any further intervention.
Eight of 28 procedures had placement of the malposi-
tioned stent in a suboptimal location, requiring a sec-
ond (n ¼ 7), or third (n ¼ 1) stent, culminating in a
successful outcome. Six patients encountered aortic (n
¼ 2) or peripheral vascular complications (n ¼ 4)
associated with stent migration.
Balloon rupture. Balloon rupture during initial stent
deployment was encountered in 2.3% (13/565) of all
procedures. In 9/13 (69%) instances, balloon rupture was
associated with the use of Palmaz (P8) stents (P ¼
0.01). Initial balloon size did not correlate with balloon
rupture. Balloon rupture was implicated in five stent
migrations and as the possible etiology of a procedure
associated CVA. In one case, a balloon fragment embo-
lized to the left axillary artery requiring surgical removal.
Fig. 2. (a–d) Imaging performed in a 42-year-old lady who
underwent stent placement of her native coarctation of the
aorta. (a) Injection in the aorta prior to stent placement. The
narrowed segment measured 7 mm with the native vessel
measuring 15 mm diameter. (b) Injection performed immedi-
ately following stent placement, extravasation of contrast is
noted outside the Genesis stent (arrow). The narrowed section
of the stent measured 11 mm diameter (Ball:Coarct ratio 1:6).
(c) CT scan of the aorta 24 hours after the intervention, with
near transaction of the aorta noted at the level of the stent
(arrow). Circumferential periaortic wall hemtoma is observed.
(d) CT scan 30 days after the intervention, noting complete re-
solution of the aortic wall hematoma. No evidence of aneu-
rysm nor dissection observed.
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Cerebral vascular accident. A cerebral vascular
accident (CVA) occurred in 4/565 (0.7%) of proce-
dures. In all but one case, complete recovery occurred,
with the fourth case having near complete return to
preintervention neurological status. Of note, two
patients who encountered rupture of their aorta during
the procedure, noted previously in the aortic dissection
section, and suffered severe neurologic injuries because
of volume loss, were not included in this analysis. The
etiology of the CVA remains speculative but was asso-
ciated with technical complications in 3/4 procedures
(two stent migrations and one balloon rupture). The
location of the strokes in two patients was related to
wire positioning within the associated vessel. All
patients were heparinized for the catheterization proce-
dure, maintaining ACTs > 250 sec.
Injury to access vessels. Hemostasis was achieved
almost exclusively in our patients via pressure dressing
with immediate sheath removal following the proce-
dure. Though a couple of patients underwent device
closure, the low number prevented any reasonable
analysis. Significant femoral arterial injury was ob-
served in 13 procedures (2.3%). The majority were
conservatively managed with observation (10/13) with
one patient developing a retroperitoneal hematoma due
to high puncture point that required surgical evacua-
tion, and two others requiring heparin therapy. Access
vessel injury was not associated with other complica-
tions, sheath size, or era in performing the catheteriza-
tion procedure.
Stent overlap of brachiocephalic vessels. This ob-
servation was treated separately as the clinical rele-
vance of this occurrence may be minimal. Out of 343
procedures where specific mention was made about
stent overlap of brachiocephalic vessels, 61 (17.8%)
had either partial or complete overlap of one of the
brachiocephalic vessels. No acute complications were
encountered, nor was there any noticeable obstruction
to flow into the involved vessel following the proce-
dure for 60/61 cases of overlap. One patient had a cov-
ered stent placed over a stented coarctation site that
overlapped the left subclavian artery resulting in dimin-
ished flow to it. Another patient had coarctation involv-
ing the origin of the left subclavian artery. After suc-
cessful stent implantation, balloon angioplasty of the
origin was carried out through the struts of the stent. At
a mean follow-up of 3.1 years with a 186 patient year
follow-up, no CVAs or peripheral embolic events have
been encountered through the affected vessels.
DISCUSSION
IS placement remains a technically demanding pro-
cedure with a high incidence of encountering compli-
cations for treatment of coarctation or the aorta. This
study is the first multi-institutional study assessing the
efficacy and safety of performing this procedure in
children and adults, specifically addressing acute com-
plications associated with the procedure. In this study,
we separated complications into aortic wall and techni-
cal complications. Our experience suggests that treat-
ment of native and recurrent coarctation of the aorta
with ISs, even in patients with complex congenital
anomalies, was frequently a successful procedure. Our
results are supported by other studies, with acute suc-
cess rates approaching 100% [2,7–14]. Though we
didn’t specifically evaluate balloon angioplasty in this
article, reintervention following balloon angioplasty
was low in our experience, suggesting that primarily
performing this procedure, especially in younger chil-
dren, is a reasonable option. Our experience has con-
firmed what others have experienced. This procedure is
technically very demanding and can be associated with
serious, albeit rare, complications [2,7–14]. The 14.2%
incidence of acute complications reported in our study
is high. The observed 31% incidence of complications
in patients 40 years of age, makes this a high risk
group.
Aortic Wall Complications
Acute aortic wall complications though rare, have
been associated with both balloon angioplasty [15–19]
and IS placement [9,10,20,21]. In our study, the per-
formance of aggressive prestent angioplasty signifi-
cantly increased the likelihood of encountering aortic
wall complications. Though speculative, this may be
due to disruption of the endothelium during the initial
balloon angioplasty procedure, with further sheath and
wire maneuvers, causing additional trauma to the
vessel wall. Our experience would indicate that aggres-
sive preballoon angioplasty should not be performed,
at least in the same setting prior to stent placement.
Though, the use of low atmosphere (<2 ATMs) for
assessment of an aortic fold (pseudocoarctation) is
routinely performed by the authors, formal aortic wall
balloon compliance testing is not routinely performed.
Surprisingly, balloon:coarctation ratios were not associ-
ated with the development of acute aortic wall compli-
cations of any type. In our experience, older age
significantly increased the likelihood of encountering
aortic wall complications. This is also consistent with
what has been reported in the literature. Four case
reports of aortic dissection shortly after stenting have
been described; [20,21,22,23]. In two patients the
aortic wall may have been weakened by other diseases
(irradiation in a 44-year-old woman [20] and muco-
polysacharride infiltration shown on autopsy in a
65-year-old) [21]. We feel this is due to decreased
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aortic wall compliance observed in this group. Studies
of aortic wall compliance in humans [24] indicate that
compliance decreases as patients reach adulthood [24–
27]. Structural changes are believed to play a major
role in age-associated decline in arterial compliance.
The most important changes are thought to be: [1]
increased fragmentation and decreased density of elas-
tin in the arterial wall; [2] increased collagen content
mediated by increased synthesis and decreased turn-
over; and [3] increased cross linking of collagen mole-
cules associated with increased advanced glycation
end-products [26,27]. In all likelihood, the adult aorta
may be less resilient to expansion than a child/adoles-
cent aorta. The difficulty lies in accurately and reliably
assessing aortic wall compliance before performing
transcatheter intervention. Pedra et al. advocated the
use of intravascular ultrasound in high risk patients, in
the hopes of identifying diseased segments of the aorta
(ie cystic medial necrosis, calcific nodules), which may
change one’s approach to the procedure [14]. In older
patients, it may be more prudent to aim for hemody-
namic success rather than angiographic resolution of
the stenosis. Unfortunately, at this time, in the United
States, there are no bailout covered stents that would
assist the interventionalist in the treatment of signifi-
cant arterial injury if it should occur during initial IS
placement. Regarding development of intimal tears im-
mediately following IS placement, no reports have
been observed in the literature, which differs from the
experience in performing balloon angioplasty alone for
treatment of coarctation of the aorta [15,16].
Technical Complications
The most frequent technical complication encoun-
tered in our study was stent migration. Stent migration
has been described in other studies, with occurrence
ranging from 0 to 6.1% in smaller reports [2,6,7,9]. In
one report, late asymptomatic stent migration was
noted in a patient three weeks following the procedure
[8]. In review of the literature, the most common
causes for stent migration were either balloon rupture
during stent deployment or deployment of the stent on
an undersized balloon catheter (with respect to diame-
ter of the proximal aorta). In our experience, using an
undersized balloon delivery catheter was the second
most common cause of stent migration, only occurring
in patients with a fold (not a true coarctation) in their
aorta. In contrast, nearly 50% of stent migrations in
our study occurred due to delivery of the stent on a
balloon catheter that was larger (oversized) than the
proximal transverse aortic diameter. The combination
of traversing the aortic arch with a straight balloon
catheter, occlusion of the majority of the cardiac out-
put, and the use of larger balloon delivery catheters,
may increase the likelihood of encountering stent/bal-
loon catheter migration during deployment. Use of
BIB catheters, with a more controlled inflation, may
decrease the likelihood of encountering stent migration.
However, in our early experience in deployment of
stents on BIB catheters, there was no notable decrease
in encountering stent migrations (8/28 stent migrations
used BIB). Use of cardiac output controlling measures
(right ventricular pacing, adenosine infusion) or place-
ment of a wire in a brachiocephalic vessel may also
decrease the likelihood of encountering this complica-
tion. These methods were not formally evaluated in
our study.
The second most common technical complication
encountered was balloon rupture during initial stent
deployment. Previous reports suggest that balloon rup-
ture incidence during stent deployment ranged from 0
to 4% [2,6,7,9]. Complications associated with balloon
rupture included the need for surgical removal of the
embolized balloon catheter [2] and occurrence of a
myocardial infarction during attempted retrieval of an
embolized balloon catheter [8]. In our study, balloon
rupture was more likely to be encountered with the
Palmaz ‘‘8’’ series stents. This may be due to the
sharp edges present in this stent, though could also be
related to the older balloon technology used with these
stents. The introduction of new balloon technology,
combined with the more recent series stents having
rounded edges, encountering balloon rupture during
initial stent deployment appears to be decreasing.
The significant decrease observed in technical com-
plications in procedures performed after January 2002
is encouraging. The reason for this could be multi-fac-
torial, with the introduction of newer stents and balloon
catheters over this period, the interventionalist had
greater options in performing the procedure, though one
could not exclude a ‘‘learning curve’’ phenomenon
with this procedure.
Peripheral Vascular Complications
In our experience, older age was associated with the
occurrence of a CVA during stent deployment. Older
patients, especially hypertensive patients, may have
early vascular disease and atheromatous changes in the
vessel wall. This should be kept in mind while manip-
ulating a wire or catheter in a brachiocephalic vessel
in these patients. Certain centers preferred to position
the delivery wire in the left subclavian artery rather
than the ascending aorta if there was a reasonable dis-
tance (>10 mm) between the coarctation segment and
takeoff of the left subclavian artery, allowing the bal-
loon catheter to remain straight during stent deploy-
ment. The recent addition of flexible stents, improve-
ment in balloon technology, and the use of cardiac
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output controlling measures, will likely decrease the
concerns of positioning the wire across the aortic arch
into the ascending aorta.
Stent overlap of brachiocephalic vessels is techni-
cally unavoidable in certain cases of transverse arch or
proximal isthmic obstruction. This occurrence has been
previously described [7]. Although, there appear to be
no acute or intermediate follow-up implications of this,
further long-term follow-up is warranted. There may
also be a theoretical issue of causing distal emboli on
performing a reintervention in a stent overlapping a
brachiocephalic vessel.
Though this article didnot specifically examine post-
operative care of patient’s undergoing stent placement
for treatment of coarctation of the aorta, there were
trends observed in the contributing authors. All felt
that one should aggressively treat post stenting hyper-
tension (systolic > 160 mm Hg and/or diastolic >
110 mm Hg) with IV antihypertensive medications to
get the systolic pressures < 150 mm Hg and diastolic
pressures < 90 mm Hg. At time of discharge, the ma-
jority felt that if the patient was on antihypertensive
medications prior to the procedure, they would con-
tinue them ranging from 1 to 4 months post stent
implant, discontinuing the medications once normal
blood pressures was recorded in the clinic. If the
patient was not taking any antihypertensive medica-
tions prior to the catheterization, a slim majority would
still start antihypertensive medications for one month,
even if the patient remained normotensive at time of
discharge. The majority of author’s would restrict the
patient from competitive sports or strenuous exercise
for 1–4 months after the procedure. All authors felt
that integrated imaging of the aortic arch should be
performed between 3 and 18 months after the catheter-
ization procedure.
Limitations
This is a retrospective study dependant on accurate
reporting by participating centers. All efforts were
made to obtain complete records of each case. Ade-
quate integrated imaging follow-up remained low in
the majority of aortic wall complications that were
encountered at time of initial stent deployment. The
number of serious complications (aortic dissection,
CVA) encountered was low, making an attempt to
accurately ascertain a possible etiology of the particu-
lar complication difficult.
CONCLUSION
Use of intravascular stenting is highly successful in
the treatment of native and recurrent coarctation of the
aorta. This procedure remains technically demanding,
with a relatively high complication rate. Though, with
recent improvements in catheter and stent technology,
encountering technical complications significantly
decreased after January 2002. Continued improvement
in balloon technology and a better understanding of
transverse aortic arch anatomy, may further help de-
crease complications associated with the procedure.
Improved assessment of aortic wall compliance in
older patients is necessary for the treatment of native
or recurrent coarctation of the aorta in this subgroup.
Prophylactic use of covered stents may play a role in
the treatment of native or recurrent coarctation of the
aorta in the older patient, or the patient with a non-
compliant aorta. We speculate that the availability of
covered stents would be an invaluable tool to have as
a ‘‘bailout’’ procedure where aortic wall dissection/
rupture has occurred, and may have a role as a pri-
mary stent in higher risk, older patients.
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